TUESDAY, July 30 (HealthDay News) -- In pediatric patients with high-grade spondylolisthesis, health-related quality of life (HRQOL) improves significantly after surgery, especially in patients with low baseline HRQOL scores, according to a study published in the July issue of The Spine Journal.
Étienne Bourassa-Moreau, M.D., from the University of Montreal, and colleagues conducted an observational case series study involving 28 pediatric patients with high-grade spondylolisthesis (23 managed surgically and five managed nonsurgically) for a minimum of two years to describe changes in HRQOL. Neurologic exams and radiographic evaluations of slip grade were conducted, and self-reported Scoliosis Research Society questionnaires (SRS-22) were administered at baseline and follow-up.
The researchers found that, at baseline and last follow-up, the total SRS-22 scores were 3.31 ± 0.50 and 4.26 ± 0.50, respectively, for surgical patients (P < 0.001). The corresponding scores for nonsurgical patients were 4.12 ± 0.16 and 4.14 ± 0.38 (P = 0.854). There was a significant correlation between improvement in the SRS-22 score and low baseline value of SRS-22. In the nonsurgical patients there was no neurologic or slip deterioration during the follow-up.
"This article demonstrated that the HRQOL significantly improves after surgery in pediatric high-grade spondylolisthesis, especially in patients with low baseline HRQOL scores," the authors write. "Nonsurgical treatment with observation of high-grade spondylolisthesis can be considered in patients with near-normal baseline HRQOL, no evidence of progression, and no neurologic impairment."
Several authors disclosed financial ties to the medical device and technology industries.
Abstract
Full Text (subscription or payment may be required)
